{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T13:32:08Z","timestamp":1767706328056,"version":"3.40.5"},"reference-count":33,"publisher":"Wiley","license":[{"start":{"date-parts":[[2022,6,17]],"date-time":"2022-06-17T00:00:00Z","timestamp":1655424000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Evidence-Based Complementary and Alternative Medicine"],"published-print":{"date-parts":[[2022,6,17]]},"abstract":"<jats:p>Although modified Liu Jun Zi decoction (MLD) has favorable outcomes for chronic atrophic gastritis (CAG) in clinics, the identification of its active ingredients and the molecular mechanism of pharmacology are still unknown and need to be solved urgently. In the study, we screened 170 active components of MLD based on oral bioavailability \u226530% and drug-likeness \u22650.18 via the TCMSP platform. We further establish a dataset containing 315 CAG targets from PharmGkb, GeneCard, OMIM, DrugBank database, and Therapeutic Target database. Network pharmacology found that there are 110 active components of MLD and 26 potential targets for CAG in the \u201cingredient-target\u201d network. The results of gene ontology analysis show that these targets are involved mainly in reactive oxygen species metabolic process, regulation of vasculature development, and T cell activation. KEGG pathways analysis indicates that these signaling pathways in the treatment of CAG include HIF-1 signaling pathway, neurodegeneration-multiple diseases pathway, MAPK signaling pathway, and PI3K-Akt signaling pathway. Finally, docking of the active component quercetin and clinical medicine Omeprazole with the core targets was carried out. We found that quercetin, a crucial active ingredient in MLD, has good binding activity with potential targets of CAG, and its molecular conformation is stable, which is better than the binding energy of Omeprazole. So, the active ingredients of MLD exhibit good potential drugs for the treatment of CAG.<\/jats:p>","DOI":"10.1155\/2022\/7536042","type":"journal-article","created":{"date-parts":[[2022,6,17]],"date-time":"2022-06-17T21:50:16Z","timestamp":1655502616000},"page":"1-12","source":"Crossref","is-referenced-by-count":3,"title":["Network Pharmacology Approach to Investigate the Mechanism of Modified Liu Jun Zi Decoction in the Treatment of Chronic Atrophic Gastritis"],"prefix":"10.1155","volume":"2022","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5356-4457","authenticated-orcid":true,"given":"Ming","family":"Zhou","sequence":"first","affiliation":[{"name":"Nanjing University of Chinese Medicine, School of Chinese Medicine, School of Integrated Chinese and Western Medicine, Nanjing 210023, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","reference":[{"key":"1","doi-asserted-by":"publisher","DOI":"10.1615\/JEnvironPatholToxicolOncol.2018026839"},{"issue":"5","key":"2","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1111\/j.1530-0277.2009.00908.x","article-title":"Chronic atrophic gastritis and metachronous gastric cancer in Japanese alcoholic men with esophageal squamous cell carcinoma","volume":"33","author":"A. Yokoyama","year":"2010","journal-title":"Alcoholism: Clinical and Experimental Research"},{"key":"3","doi-asserted-by":"publisher","DOI":"10.1186\/s12929-018-0485-6"},{"key":"4","doi-asserted-by":"publisher","DOI":"10.15430\/jcp.2015.20.1.25"},{"key":"5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijscr.2020.06.010"},{"key":"6","doi-asserted-by":"publisher","DOI":"10.1016\/s0889-8553(02)00008-0"},{"key":"7","article-title":"Consensus on chronic gastritis in China \u2013 second national consensus meeting on chronic gastritis (14\u201316 september 2006 Shanghai, China)","volume":"8","author":"J. Y. Fang","year":"2007","journal-title":"Journal of Digestive Diseases"},{"key":"8","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-199447020-00006"},{"key":"9","article-title":"Third Chinese national consensus report on the management of Helicobacter pylori infection","volume":"9","author":"F. L. Hu","year":"2010","journal-title":"Journal of Digestive Diseases"},{"key":"10","article-title":"Helicobacter pylori eradication for the prevention of gastric neoplasia","volume":"7","author":"P. Moayyedi","year":"2006","journal-title":"The Cochrane Database of Systematic Reviews"},{"key":"11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0133159"},{"key":"12","doi-asserted-by":"publisher","DOI":"10.1186\/s12906-019-2580-y"},{"key":"13","article-title":"A novel chemometric method for the prediction of human oral bioavailability","volume":"13","author":"X. Xu","year":"2012","journal-title":"International Journal of Molecular Sciences"},{"key":"14","doi-asserted-by":"publisher","DOI":"10.1101\/gr.1239303"},{"issue":"1","key":"15","doi-asserted-by":"crossref","first-page":"5","DOI":"10.2174\/138920021801170119204832","article-title":"Protein-protein interaction (PPI) network: recent advances in drug discovery","volume":"18","author":"A. Athanasios","year":"2017","journal-title":"Current Drug Metabolism"},{"key":"16","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gku1003"},{"key":"17","doi-asserted-by":"publisher","DOI":"10.1016\/j.biosystems.2014.11.005"},{"key":"18","doi-asserted-by":"publisher","DOI":"10.4238\/gmr.15027358"},{"issue":"10","key":"19","doi-asserted-by":"crossref","DOI":"10.1002\/jcp.28452","article-title":"Quercetin attenuates oxidative stress\u2010induced apoptosis via SIRT1\/AMPK\u2010mediated inhibition of ER stress in rat chondrocytes and prevents the progression of osteoarthritis in a rat model","volume":"234","author":"K. Feng","year":"2019","journal-title":"Journal of Cellular Physiology"},{"key":"20","article-title":"Kaempferol inhibits interleukin1\u03b2 stimulated matrix metalloproteinases by suppressing the MAPKassociated ERK and P38 signaling pathways","volume":"18","author":"X. Huang","year":"2018","journal-title":"Molecular Medicine Reports"},{"key":"21","doi-asserted-by":"publisher","DOI":"10.12659\/msm.902491"},{"key":"22","doi-asserted-by":"crossref","DOI":"10.3390\/ph12010011","article-title":"The therapeutic potential of naringenin: a review of clinical trials","volume":"12","author":"B. Salehi","year":"2019","journal-title":"Pharmaceuticals"},{"key":"23","doi-asserted-by":"publisher","DOI":"10.1016\/0014-5793(96)00266-9"},{"key":"24","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.epi-13-0263"},{"key":"25","doi-asserted-by":"publisher","DOI":"10.4161\/cbt.7.5.5712"},{"issue":"24","key":"26","first-page":"6788","article-title":"Oncogenic mutations of the p53 tumor suppressor: the demons of the guardian of the genome","volume":"60","author":"A. Sigal","year":"2000","journal-title":"Cancer Research"},{"key":"27","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2010.05.010"},{"issue":"6","key":"28","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1016\/S0002-9440(10)63265-8","article-title":"The CC chemokine ligand, CCL2\/MCP1, participates in macrophage fusion and foreign body giant cell formation","volume":"165","author":"T. R. Kyriakides","year":"2005","journal-title":"American Journal Of Pathology"},{"issue":"4","key":"29","first-page":"363","article-title":"The role of cytokines in non-alcoholic steatohepatitis. A review","volume":"15","author":"I. Copaci","year":"2007","journal-title":"Journal of gastrointestinal and liver diseases: JGLD"},{"key":"30","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2017.09.003"},{"key":"31","article-title":"Effect of huazhuo jiedu hewei recipe on the mechanism of angiogenesis in precancerous lesions of gastric cancer rats","volume":"33","author":"S. F. Gao","year":"2013","journal-title":"Chinese Journal of Integrated Traditional & Western Medicine"},{"key":"32","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2019.172481","article-title":"Vanillic acid attenuates cartilage degeneration by regulating the MAPK and PI3K\/AKT\/NF-\u03baB pathways","volume":"859","author":"X. Huang","year":"2019","journal-title":"European Journal of Pharmacology"},{"key":"33","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2018.9329"}],"container-title":["Evidence-Based Complementary and Alternative Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/downloads.hindawi.com\/journals\/ecam\/2022\/7536042.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/downloads.hindawi.com\/journals\/ecam\/2022\/7536042.xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/downloads.hindawi.com\/journals\/ecam\/2022\/7536042.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,17]],"date-time":"2022-06-17T21:50:27Z","timestamp":1655502627000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.hindawi.com\/journals\/ecam\/2022\/7536042\/"}},"subtitle":[],"editor":[{"given":"Hongsheng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2022,6,17]]},"references-count":33,"alternative-id":["7536042","7536042"],"URL":"https:\/\/doi.org\/10.1155\/2022\/7536042","relation":{},"ISSN":["1741-4288","1741-427X"],"issn-type":[{"type":"electronic","value":"1741-4288"},{"type":"print","value":"1741-427X"}],"subject":[],"published":{"date-parts":[[2022,6,17]]}}}